LENZ Therapeutics, Inc.

Biotechnology • Healthcare • Solana Beach, CA, United States • LENZ (NMS)

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

858 925 7000 201 Lomas Santa Fe Drive, Solana Beach, CA 92075, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

FDA-approved presbyopia eye drop VIZZ to reach Middle East - Stock Titan

Stock Titan • Jan 5

LENZ Therapeutics: Was That A Market Overreaction? (NASDAQ:LENZ) - Seeking Alpha

Seeking Alpha • Dec 17

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - LENZ Therapeutics

LENZ Therapeutics • Nov 5

Lenz, Lunatus announce exclusive partnership for VIZZ in Middle East - TipRanks

TipRanks • Jan 5

LENZ Therapeutics (NASDAQ:LENZ) Hits New 1-Year Low - What's Next? - MarketBeat

MarketBeat • Jan 2

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has LENZ Therapeutics, Inc. had layoffs?

No layoff events have been recorded for LENZ Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is LENZ Therapeutics, Inc. in?

LENZ Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is LENZ Therapeutics, Inc. a publicly traded company?

Yes, LENZ Therapeutics, Inc. is publicly traded under the ticker symbol LENZ on the NMS. The company has a market capitalization of approximately $0.53 billion.

Where is LENZ Therapeutics, Inc. headquartered?

LENZ Therapeutics, Inc. is headquartered in Solana Beach, CA, United States at 201 Lomas Santa Fe Drive, Solana Beach, CA 92075, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.